Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni Syndrome.
Clin Gastroenterol Hepatol
; 22(3): 662-665.e1, 2024 Mar.
Article
em En
| MEDLINE
| ID: mdl-37714395
ABSTRACT
Li-Fraumeni syndrome (LFS), linked to heterozygous germline pathogenic/likely pathogenic variants in TP53, confers exceptionally high cancer risk, including core cancers (sarcoma, breast, adrenocortical, and brain cancer) among many other cancer types.1 Colorectal cancer (CRC) is most common after the core and hematologic cancers, accounting for â¼2.8% of diagnoses. Stomach and esophageal cancers constitute another 1.3% (TP53 Database; R20, July 2019 https//tp53.isb-cgc.org).2.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Síndrome de Li-Fraumeni
/
Neoplasias Gastrointestinais
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article